Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Maitreya Medicare's share price for the quarter that ended in Mar. 2026 was ₹178.85. Maitreya Medicare's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 0.07 Mil. Therefore, Maitreya Medicare's market cap for the quarter that ended in Mar. 2026 was ₹12.16 Mil.
Maitreya Medicare's quarterly market cap
declined
from Mar. 2025 (₹2,070.41 Mil) to Sep. 2025 (₹16.50 Mil) and
declined
from Sep. 2025 (₹16.50 Mil) to Mar. 2026 (₹12.16 Mil).
Maitreya Medicare's annual market cap
increased
from Mar. 2023 (₹0.00 Mil) to Mar. 2025 (₹2,070.41 Mil) but then
declined
from Mar. 2025 (₹2,070.41 Mil) to Mar. 2026 (₹12.16 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Maitreya Medicare's Enterprise Value for Today is ₹937.46 Mil.
Maitreya Medicare (NSE:MAITREYA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Maitreya Medicare Market Cap Related Terms
Maitreya Medicare Market Cap Historical Data
* Premium members only.
The historical data trend for Maitreya Medicare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAITREYA vs HCA, DVA, THC: Market Cap Comparison
For the Medical Care Facilities subindustry, Maitreya Medicare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maitreya Medicare Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's Market Cap distribution charts can be found below:
* The bar in red indicates where Maitreya Medicare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Maitreya Medicare's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maitreya Medicare (NSE:MAITREYA) has a Market Cap of ₹786.02 Mil as of Sep. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Maitreya Medicare and its competitors. According to the industry distribution chart, Maitreya Medicare ranks #596 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 85.8%.
Is Maitreya Medicare's Market Cap too high?
Maitreya Medicare's current Market Cap is ₹786.02 Mil. Based on the distribution chart, Maitreya Medicare ranks #596 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Maitreya Medicare has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Market Cap compare to HCA and DVA?
According to the Healthcare Providers & Services industry distribution chart, Maitreya Medicare ranks #596 out of 695 companies for Market Cap. This places Maitreya Medicare in the lower half of its industry. The industry median Market Cap is 101.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 101.76, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Maitreya Medicare and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 101.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maitreya Medicare's current Market Cap is ₹786.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Based on GuruFocus' analysis, Maitreya Medicare (NSE:MAITREYA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹459.91, compared to a current price of ₹116.00 — trading 74.8% below its estimated fair value. The current Market Cap is ₹786.02 Mil. Maitreya Medicare's overall GF Score™ is 26/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Market Cap is ₹786.02 Mil as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maitreya Medicare (NSE:MAITREYA) Overvalued in 2026?
Based on GuruFocus' analysis, Maitreya Medicare stock appears to be undervalued.
The current stock price of ₹116.00 is trading 74.8% below its estimated GF Value™ of ₹459.91.
GuruFocus considers Maitreya Medicare to be Possible Value Trap.
Key valuation signals for NSE:MAITREYA:
Market Cap: ₹786.02 Mil
GF Value™: ₹459.91 vs. price of ₹116.00 (74.8% below fair value)
No single metric tells the full story. See the NSE:MAITREYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
26GF Score
Get the complete analysis for NSE:MAITREYA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAITREYA has been successfully added to your 
